mtm laboratories and EMBL (European Molecular Biology Laboratory) in cancer link-up:
This article was originally published in Clinica
Executive Summary
mtm laboratories (Heidelberg, Germany) is to validate the transcript, protein and tissue expression profiles of molecular marker candidates for colorectal and lung cancers under an agreement with the commercial arm of the European Molecular Biology Laboratory. It will fund the co-operative work through a Prolnno grant from the German ministry of economics, and will have commercialisation rights on identified markers. The two partners will make joint patent applications. The aim is to enable early detection and prevention of the cancers by combining EMBL's bioinformatics expertise and databanks with mtm's experience in marker-based diagnostics and therapeutics.